← Open Payments lookup

MARK FOLTS: Open Payments

NPI 1629068614 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,798 in 207 payments from 17 companies in 2025. Trend: 2023 $2,382 · 2024 $3,002 · 2025 $3,798

Food & beverage: $3,699Education: $100
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.25$463
ABBVIE INC.30$436
Neurocrine BioSciences, Inc.20$385
Teva Pharmaceuticals USA, Inc.13$368
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)28$346
Vanda Pharmaceuticals Inc.21$345
Lundbeck LLC14$317
Janssen Pharmaceuticals, Inc15$313
Axsome Therapeutics, Inc.9$232
E.R. Squibb & Sons, L.L.C.10$157

Products named: REXULTI, VRAYLAR, INGREZZA, CAPLYTA, FANAPT, SPRAVATO, Auvelity, UZEDY.

Industry payments across MI — which companies pay providers there.